Search results
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 3 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 17 hours agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 16 hours agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 8 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Celebrity doctors promoted Covid vaccine without declaring payments
The Telegraph via Yahoo News· 2 hours agoThe pharmaceutical watchdog has been urged to investigate after a string of celebrity doctors took...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 3 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 4 hours agoThis is admittedly not an ideal formula for growth. However, I think the worst is over for Pfizer's...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 1 day agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...